Literature DB >> 10697551

MHC-class-I expression in human breast cancer correlates with nuclear localization of the 90 kDa heat-shock-protein.

B Gebhard1, G Schütz, R C Ecker, G E Steiner, M Rudas, M Gnant, R Oehler.   

Abstract

Breast cancer cells frequently exhibit a reduction in expression of major-histocompatibility-complex (MHC) class I proteins which blocks cytotoxic T-lymphocyte (CTL) mediated apoptosis. Recent studies indicate that the 90 kD heat-shock-protein (HSP90) plays a major role in the transfer of antigenic peptides to the MHC class I complex. HSP90 is a molecular chaperone which is involved in signal transduction and regulation of apoptosis. Since HSP90 is described to be elevated in breast cancer, its relationship with MHC class I expression was investigated. Using immunohistochemistry we analyzed the expression and localization of HSP90 and MHC class I in 17 human breast tumors. Positive correlation (p < 0.025) between strong nuclear staining for HSP90 and high MHC class I expression was observed. In tumors with reduced MHC class I expression, no nuclear localization of HSP90 was detectable. These findings lead to the hypothesis that tumor cells with high MHC class I expression and susceptibility to CTL action may escape apoptosis by a mechanism which involves increased nuclear HSP90.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10697551

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions.

Authors:  Flora Zagouri; Theodoros N Sergentanis; Afrodite Nonni; Christos A Papadimitriou; Nikolaos V Michalopoulos; Philip Domeyer; George Theodoropoulos; Andreas Lazaris; Effstratios Patsouris; Eleni Zogafos; Anastazia Pazaiti; George C Zografos
Journal:  BMC Cancer       Date:  2010-07-05       Impact factor: 4.430

2.  Decreased Hsp90 expression in infiltrative lobular carcinoma: an immunohistochemical study.

Authors:  Flora Zagouri; Theodoros Sergentanis; Afrodite Nonni; Christos Papadimitriou; Anastasia Pazaiti; Nikolaos V Michalopoulos; Panagiotis Safioleas; Andreas Lazaris; George Theodoropoulos; Effstratios Patsouris; George Zografos
Journal:  BMC Cancer       Date:  2010-08-06       Impact factor: 4.430

3.  Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin.

Authors:  X Wu; A Wanders; P Wardega; B Tinge; L Gedda; S Bergstrom; L Sooman; J Gullbo; M Bergqvist; P Hesselius; J Lennartsson; S Ekman
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

4.  Heat shock protein90 in lobular neoplasia of the breast.

Authors:  Flora Zagouri; Afrodite Nonni; Theodoros N Sergentanis; Christos A Papadimitriou; Nikolaos V Michalopoulos; Andreas C Lazaris; Efstratios Patsouris; George C Zografos
Journal:  BMC Cancer       Date:  2008-10-28       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.